Literature DB >> 19266472

Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants.

Andrew J Conley1, Jussi J Joensuu, Anthony M Jevnikar, Rima Menassa, Jim E Brandle.   

Abstract

The demand for recombinant proteins for medical and industrial use is expanding rapidly and plants are now recognized as an efficient, inexpensive means of production. Although the accumulation of recombinant proteins in transgenic plants can be low, we have previously demonstrated that fusions with an elastin-like polypeptide (ELP) tag can significantly enhance the production yield of a range of different recombinant proteins in plant leaves. ELPs are biopolymers with a repeating pentapeptide sequence (VGVPG)(n) that are valuable for bioseparation, acting as thermally responsive tags for the non-chromatographic purification of recombinant proteins. To determine the optimal ELP size for the accumulation of recombinant proteins and their subsequent purification, various ELP tags were fused to green fluorescent protein, interleukin-10, erythropoietin and a single chain antibody fragment and then transiently expressed in tobacco leaves. Our results indicated that ELP tags with 30 pentapeptide repeats provided the best compromise between the positive effects of small ELP tags (n = 5-40) on recombinant protein accumulation and the beneficial effects of larger ELP tags (n = 80-160) on recombinant protein recovery during inverse transition cycling (ITC) purification. In addition, the C-terminal orientation of ELP fusion tags produced higher levels of target proteins, relative to N-terminal ELP fusions. Importantly, the ELP tags had no adverse effect on the receptor binding affinity of erythropoietin, demonstrating the inert nature of these tags. The use of ELP fusion tags provides an approach for enhancing the production of recombinant proteins in plants, while simultaneously assisting in their purification. 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266472     DOI: 10.1002/bit.22278

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  45 in total

Review 1.  Designing protein-based biomaterials for medical applications.

Authors:  Jennifer E Gagner; Wookhyun Kim; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

2.  Hydrophobin fusions for high-level transient protein expression and purification in Nicotiana benthamiana.

Authors:  Jussi J Joensuu; Andrew J Conley; Michael Lienemann; Jim E Brandle; Markus B Linder; Rima Menassa
Journal:  Plant Physiol       Date:  2009-12-11       Impact factor: 8.340

Review 3.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

4.  Native-sized spider silk proteins synthesized in planta via intein-based multimerization.

Authors:  Valeska Hauptmann; Nicola Weichert; Matthias Menzel; Dominic Knoch; Norman Paege; Jürgen Scheller; Uwe Spohn; Udo Conrad; Mario Gils
Journal:  Transgenic Res       Date:  2012-09-22       Impact factor: 2.788

Review 5.  Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.

Authors:  Jordan Despanie; Jugal P Dhandhukia; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  J Control Release       Date:  2015-11-11       Impact factor: 9.776

6.  Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy.

Authors:  Doreen Manuela Floss; Michael Mockey; Galliano Zanello; Damien Brosson; Marie Diogon; Roger Frutos; Timothée Bruel; Valérie Rodrigues; Edwin Garzon; Claire Chevaleyre; Mustapha Berri; Henri Salmon; Udo Conrad; Laurence Dedieu
Journal:  J Biomed Biotechnol       Date:  2010-04-13

Review 7.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

8.  Expression and purification of an anti-Foot-and-mouth disease virus single chain variable antibody fragment in tobacco plants.

Authors:  J J Joensuu; K D Brown; A J Conley; A Clavijo; R Menassa; J E Brandle
Journal:  Transgenic Res       Date:  2009-04-03       Impact factor: 2.788

Review 9.  Applications of elastin-like polypeptides in drug delivery.

Authors:  Sarah R MacEwan; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

10.  A tunable and reversible platform for the intracellular formation of genetically engineered protein microdomains.

Authors:  Martha K Pastuszka; Siti M Janib; Isaac Weitzhandler; Curtis T Okamoto; Sarah Hamm-Alvarez; J Andrew Mackay
Journal:  Biomacromolecules       Date:  2012-10-25       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.